Aethlon Medical is a leading developer of immunotherapeutic technologies. It creates medical devices for cancer, infectious diseases and other life-threatening conditions. The company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. At present, the Hemopurifier® is being advanced under an FDA approved clinical study. Founded in 1991, the company is headquartered in San Diego, California.